These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1024 related items for PubMed ID: 16950988

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM, Rhodes P, Connelly BL, Bi D, Hahn C, Patrick S, Glodé MP, Ehresmann KR, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. kbisgard@cdc.gov.
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [Abstract] [Full Text] [Related]

  • 3. [Time for booster doses against whooping cough for 10-year-old children].
    Carlsson RM, Ekholm L, Gothefors L, Granström M, Trolin I, Tegnell A.
    Lakartidningen; 2005 Aug; 102(35):2394-8. PubMed ID: 16184889
    [Abstract] [Full Text] [Related]

  • 4. Pertussis vaccination in infancy lowers the incidence of pertussis disease and the rate of hospitalisation after one and two doses: analyses of 10 years of pertussis surveillance.
    Nilsson L, Lepp T, von Segebaden K, Hallander H, Gustafsson L.
    Vaccine; 2012 May 02; 30(21):3239-47. PubMed ID: 22094282
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Impact of a pertussis booster vaccination program in adolescents and adults on the epidemiology of pertussis in Austria.
    Rendi-Wagner P, Paulke-Korinek M, Stanek G, Khanakah G, Kollaritsch H.
    Pediatr Infect Dis J; 2007 Sep 02; 26(9):806-10. PubMed ID: 17721375
    [Abstract] [Full Text] [Related]

  • 9. Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands.
    de Greeff SC, Mooi FR, Schellekens JF, de Melker HE.
    Pediatr Infect Dis J; 2008 Mar 02; 27(3):218-23. PubMed ID: 18277916
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Control of pertussis in the world.
    Galazka A.
    World Health Stat Q; 1992 Mar 02; 45(2-3):238-47. PubMed ID: 1462658
    [Abstract] [Full Text] [Related]

  • 12. Safety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.
    Zepp F, Knuf M, Habermehl P, Mannhardt-Laakmann W, Howe B, Friedland LR.
    J Pediatr; 2006 Nov 02; 149(5):603-610. PubMed ID: 17095328
    [Abstract] [Full Text] [Related]

  • 13. Hospital-based active surveillance of childhood pertussis in Austria from 1996 to 2003: estimates of incidence and vaccine effectiveness of whole-cell and acellular vaccine.
    Rendi-Wagner P, Kundi M, Mikolasek A, Vécsei A, Frühwirth M, Kollaritsch H.
    Vaccine; 2006 Aug 14; 24(33-34):5960-5. PubMed ID: 16757063
    [Abstract] [Full Text] [Related]

  • 14. [Vaccine protection of Swedish children. Time for revision of replacing doses of diphtheria, tetanus, polio and pertussis].
    Olin P.
    Lakartidningen; 2001 Aug 29; 98(35):3654-7. PubMed ID: 11577639
    [Abstract] [Full Text] [Related]

  • 15. Pertussis before and after the introduction of acellular pertussis vaccines in Finland.
    Elomaa A, He Q, Minh NN, Mertsola J.
    Vaccine; 2009 Sep 04; 27(40):5443-9. PubMed ID: 19628060
    [Abstract] [Full Text] [Related]

  • 16. The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada.
    Bettinger JA, Halperin SA, De Serres G, Scheifele DW, Tam T.
    Pediatr Infect Dis J; 2007 Jan 04; 26(1):31-5. PubMed ID: 17195702
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pertussis antitoxin decay after vaccination with DTPa. Response to a first booster dose 3 1/2-6 1/2 years after the third vaccine dose.
    Hallander HO, Gustafsson L, Ljungman M, Storsaeter J.
    Vaccine; 2005 Nov 16; 23(46-47):5359-64. PubMed ID: 16051400
    [Abstract] [Full Text] [Related]

  • 19. Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age.
    Hendrikx LH, de Rond LG, Oztürk K, Veenhoven RH, Sanders EA, Berbers GA, Buisman AM.
    Vaccine; 2011 Aug 05; 29(34):5725-30. PubMed ID: 21669247
    [Abstract] [Full Text] [Related]

  • 20. Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life.
    Knuf M, Habermehl P, Faber J, Bock HL, Sänger R, Bogaerts H, Clemens R, Schuind A, du Prel JB, Schmitt HJ.
    Vaccine; 2006 Jul 07; 24(27-28):5627-36. PubMed ID: 16740348
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.